Partners Michele Buenafe, Jacob Harper, and Andrew Gray wrote the first of a two-part article series for Med Device Online, covering the existing US Food and Drug Administration (FDA) programs, recently issued guidance impacting artificial intelligence and machine learning technologies intended for use in healthcare, and what to expect from the FDA’s FY 2023 priority list.